Your browser doesn't support javascript.
loading
Early Symptomatic Improvement After Ustekinumab Therapy in Patients With Ulcerative Colitis: 16-Week Data From the UNIFI Trial.
Danese, Silvio; Sands, Bruce E; Abreu, Maria T; O'Brien, Christopher D; Bravatà, Ivana; Nazar, Maciej; Miao, Ye; Wang, Yanli; Rowbotham, David; Leong, Rupert W L; Arasaradnam, Ramesh P; Afif, Waqqas; Marano, Colleen.
  • Danese S; Gastroenterology and Endoscopy, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale San Raffaele and Università Vita-Salute San Raffaele, Milan, Italy. Electronic address: sdanese@hotmail.com.
  • Sands BE; Dr Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, New York.
  • Abreu MT; Division of Gastroenterology, Department of Medicine, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida.
  • O'Brien CD; Biostatistics Department, Janssen Research and Development, LLC, Spring House, Pennsylvania.
  • Bravatà I; Medical Affairs, Janssen-Cilag SpA, Milan, Italy.
  • Nazar M; Medical Affairs, Janssen-Cilag Polska Sp. z o.o, Warsaw, Poland.
  • Miao Y; Biostatistics Department, Janssen Research and Development, LLC, Spring House, Pennsylvania.
  • Wang Y; Biostatistics Department, Janssen Research and Development, LLC, Spring House, Pennsylvania.
  • Rowbotham D; Department of Gastroenterology & Hepatology, Auckland City Hospital, Auckland, New Zealand.
  • Leong RWL; Gastroenterology and Liver Services, Concord Hospital, and Department of Gastroenterology, Macquarie University Hospital, Concord and Macquarie University Hospitals, Sydney, Australia.
  • Arasaradnam RP; Division of Gastroenterology, University Hospitals Coventry and Warwickshire National Health Service (NHS) Trust, Coventry, United Kingdom.
  • Afif W; Division of Gastroenterology and Hepatology, McGill University Health Centre, Montreal, Canada.
  • Marano C; Biostatistics Department, Janssen Research and Development, LLC, Spring House, Pennsylvania.
Clin Gastroenterol Hepatol ; 20(12): 2858-2867.e5, 2022 12.
Article en En | MEDLINE | ID: mdl-35276329

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Productos Biológicos / Colitis Ulcerosa Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Productos Biológicos / Colitis Ulcerosa Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article